Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges

Immunotherapies targeting immune checkpoints are fast-developing therapeutic approaches adopted for several tumor types that trigger unprecedented rates of durable clinical responses. Immune checkpoint programmed cell death protein 1 (PD-1), expressed primarily by T cells, and programmed cell death...

Descripción completa

Detalles Bibliográficos
Autores principales: Macek Jilkova, Zuzana, Aspord, Caroline, Decaens, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826488/
https://www.ncbi.nlm.nih.gov/pubmed/31615069
http://dx.doi.org/10.3390/cancers11101554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826488/
https://www.ncbi.nlm.nih.gov/pubmed/31615069
http://dx.doi.org/10.3390/cancers11101554

Ejemplares similares